Biokin Pharma announces approval of Iza-bren in China for the treatment of recurrent/metastatic ESCC

NMPA accepts New Drug Application for Trastuzumab Envedotin injection

Medilink announces NMPA acceptance of marketing application for Tam-Peli in 3L+ NPC

SEC recommends approval to Enhertu for two additional indications in India

Telix doses first patient in phase 3 LUTEON trial of TLX250-Tx for Renal cancer

Samsung Bioepis enters into a commercial license agreement with IntoCell for an ADC candidate